Skip to content

US · BMGL · MEDICAL - CARE FACILITIES

Basel Medical Group Ltd Ordinary Shares (BMGL) intrinsic value and stock valuation

$0.38as of 2026-11-21 · Mkt cap 8.77M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Basel Medical Group Ltd Ordinary Shares DCF and intrinsic value

InvestorsCraft values BMGL with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BMGL’s statements →

Basel Medical Group Ltd Ordinary Shares Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Care Facilities Singapore, CE 258499 baselmedical.com

How the business is doing

Fiscal 2022–2025, USD

Revenue
$11.3M
20222025
Net income
-$-12.09M
20222025
Free cash flow
-$-4.4M
20222025
Total equity
$4.86M
20222025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2022–2025, USD
2025202420232022
Revenue$11.3M$10.1M$9.7M$10.7M
Operating income-$-2.18M$2.2M$2M$2.47M
Net income-$-12.09M$2.07M$1.78M$1.98M
EPSd-$-7.7M$1.53M$1.32M$1.47M
Operating cash flow-$-4.34M$2.51M$2.6M$2.79M
Capital expenditure-$-50K-$-10K-$-10K-$-90K
Free cash flow-$-4.4M$2.5M$2.59M$2.7M
Total assets$16.9M$16.3M$15.4M$16.9M
Total debt$3.42M$4.29M$7.21M$10.2M
Net debt$440K$2.34M$6M$8.59M
Total equity$4.86M$7.56M$5.49M$3.71M
Cash and short-term investments$2.98M$1.95M$1.22M$1.56M
Income statement
2025202420232022
Revenue$11.3M$10.1M$9.7M$10.7M
Cost of revenue$2.53M$2.25M$2.34M$2.18M
Gross profit$8.79M$7.8M$7.36M$8.48M
Research and development expenses$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$6.54M$3.64M$3.27M$4.04M
Other expenses$4.44M$1.97M$2.1M$1.96M
Operating expenses$11M$5.61M$5.36M$6.01M
Cost and expenses$13.5M$7.86M$7.7M$8.18M
Interest income$80K$0.00$300K$250K
Interest expense$200K$180K$240K$320K
Depreciation and amortization$1.18M$530K$560K$580K
Ebitda-$-11.12M$3.11M$2.93M$3.28M
Operating income-$-2.18M$2.2M$2M$2.47M
Total other income/expenses, net-$-10.32M$210K$130K-$-90K
Income before tax-$-12.51M$2.4M$2.13M$2.39M
Income tax expense-$-420K$330K$350K$410K
Net income-$-12.09M$2.07M$1.78M$1.98M
Weighted average shares outstanding$1.57M$1.35M$1.35M$1.35M
Weighted average diluted shares outstanding$1.57M$1.35M$1.35M$1.35M
Balance sheet
2025202420232022
Cash and short-term investments$2.98M$1.95M$1.22M$1.56M
Net receivables$2.49M$12.4M$13.3M$13.9M
Inventory$380K$70K$90K$70K
Total current assets$13.1M$16.2M$14.8M$15.7M
Property, plant and equipment, net$3.45M$60K$580K$1.18M
Goodwill and intangible assets$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00
Total non-current assets$3.74M$130K$610K$1.18M
Total assets$16.9M$16.3M$15.4M$16.9M
Accounts payable$2.1M$830K$1.46M$1.08M
Short-term debt$2.12M$2.71M$3.79M$4.2M
Deferred revenue$0.00$0.00$0.00$0.00
Total current liabilities$10.7M$7.16M$6.47M$7.19M
Long-term debt$1.3M$1.58M$3.42M$5.95M
Deferred revenue, non-current$0.00$0.00$0.00$0.00
Total non-current liabilities$1.3M$1.58M$3.42M$5.95M
Capital lease obligations$3.36M$30K$590K$1.21M
Total liabilities$12M$8.75M$9.89M$13.1M
Common stock$34.2M$24.5M$0.00$0.00
Retained earnings-$-4.4M$7.56M$5.49M$3.71M
Accumulated other comprehensive income (loss)-$-24.95M-$-24.46M$0.00$0.00
Total equity$4.86M$7.56M$5.49M$3.71M
Total investments$0.00$0.00$0.00$0.00
Total debt$3.42M$4.29M$7.21M$10.2M
Net debt$440K$2.34M$6M$8.59M
Cash flow statement
2025202420232022
Net income-$-12.51M$2.4M$2.13M$2.39M
Depreciation and amortization$1.18M$530K$560K$580K
Stock-based compensation$0.00$0.00$0.00$0.00
Change in working capital-$-3.25M-$0.00$290K$80K
Accounts receivable-$-7.28M-$-420K$540K$10K
Inventory-$-300K$20K-$-20K$0.00
Accounts payable$0.00$0.00$0.00$0.00
Net cash provided by operating activities-$-4.34M$2.51M$2.6M$2.79M
Investments in property, plant and equipment-$-50K-$-10K-$-10K-$-90K
Acquisitions, net-$-10.99M$0.00$0.00$0.00
Net cash used for investing activities-$-11.04M-$-10K-$-10K-$-90K
Common stock issued$9.75M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00
Net cash used for financing activities$16.9M-$-1.77M-$-2.94M-$-12.92M
Net change in cash$1.03M$730K-$-350K-$-10.22M
Cash at end of period$2.98M$1.95M$1.22M$1.56M
Operating cash flow-$-4.34M$2.51M$2.6M$2.79M
Capital expenditure-$-50K-$-10K-$-10K-$-90K
Free cash flow-$-4.4M$2.5M$2.59M$2.7M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Basel Medical Group Ltd Ordinary Shares

        Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

        CEO
        Yen Feng Chhoa
        Employees
        70
        Beta
        0.24

        Explore

        Frequently asked questions

        What is the intrinsic value of Basel Medical Group Ltd Ordinary Shares (BMGL)?

        InvestorsCraft does not currently publish an intrinsic value for BMGL. How the IC value is calculated.

        Is BMGL undervalued?

        InvestorsCraft does not publish an undervaluation signal for BMGL at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.